ArticlePharmaceutics2022

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule

Yongsheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.